Comparing the current results to its competitors, Biolife Solutions Inc reported Revenue increase in the 1 quarter 2026 by 14.85 % year on year. The sales growth was above Biolife Solutions Inc 's competitors' average revenue growth of 9.23 %, achieved in the same quarter.
Biolife Solutions Inc 's Comment on Competition and Industry Peers
The company safeguards its products using patents, trademarks, trade secrets, nondisclosure and confidentiality agreements, scientific expertise, and continuous technological innovation. Despite these measures, there is a risk that unauthorized third parties may replicate aspects of its products or utilize proprietary information.
Adma Biologics Inc operates as a biopharmaceutical company focused on producing and commercializing specialty plasma-derived biologics for various medical conditions. The company's business model revolves around collecting and fractionating plasma from qualified donors to manufacture and sell therapies for immune deficiency disorders, autoimmune diseases, and other indications. Adma Biologics markets its products directly to healthcare providers, hospitals, and other healthcare institutions while prioritizing patient safety and product quality.
Cerus Corporation's business model revolves around developing and commercializing innovative technologies and products for the enhancement of blood safety.
Cryoport Inc's business model revolves around providing temperature-controlled logistics solutions for the shipping of cryogenic products, including life sciences materials, cell and gene therapies, and reproductive medicine. The company utilizes its advanced technology and a global network of partners to ensure safe and secure transportation of these sensitive materials, catering to the needs of the rapidly growing biopharmaceutical industry.
Sources:
Biolife Solutions Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biolife Solutions Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
